[{"arm_notes": "", "treatment_id": null, "treatment_name": "Participant received viral vector vaccine will be checked the antibody level at baseline before the first dose vaccination; before second dose; 4 weeks; 24 weeks and 48 weeks after complete vaccination.;Participant received inactivated vaccine will be checked the antibody level at baseline before the first dose vaccination; before second dose; 4 weeks; 24 weeks and 48 weeks after complete vaccination.;Experimental Biological/Vaccine;Active Comparator Biological/Vaccine;Viral vector vaccine;Inactivated vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "2", "treatment_id": 1972, "treatment_name": "Viral vector covid-19 vaccine", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2", "treatment_id": 643, "treatment_name": "Inactivated covid-19 vaccine", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]